Mediolanum International Funds’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.79M Buy
76,627
+16,327
+27% +$1.62M 0.08% 238
2026
Q1
$5.45M Buy
60,300
+12,227
+25% +$1.22M 0.06% 264
2025
Q4
$4.75M Buy
48,073
+21,002
+78% +$2.03M 0.05% 272
2025
Q3
$2.27M Buy
+27,071
New +$2.14M 0.02% 331
2025
Q1
Sell
-20,916
Closed -$1.43M 443
2024
Q4
$1.43M Sell
20,916
-2,721
-12% -$194K 0.02% 349
2024
Q3
$1.55M Sell
23,637
-80,392
-77% -$5.13M 0.02% 350
2024
Q2
$5.96M Buy
104,029
+83,294
+402% +$4.72M 0.1% 198
2024
Q1
$1.18M Buy
+20,735
New +$1.24M 0.02% 335

Other funds holding INCY

Mediolanum International Funds's INCY Position: Q2 2026 in Review

Mediolanum International Funds increased its Incyte (INCY) stake by 27% in Q2 2026, buying an estimated $1.62M and bringing the position to 76,627 shares worth $8.79M. The position accounts for 0.08% of the portfolio, ranked #238.

Mediolanum International Funds first reported a position in INCY in Q1 2024 and has held it in 8 quarters since. 189 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Mediolanum International Funds held 76,627 shares of Incyte worth $8.79M as of Q2 2026.
  • Mediolanum International Funds bought 16,327 Incyte shares in Q2 2026, an estimated $1.62M.
  • Incyte made up 0.08% of Mediolanum International Funds's portfolio in Q2 2026, its #238 holding.
  • Mediolanum International Funds first reported a position in Incyte in Q1 2024 and has held it in 8 quarters since.
  • 189 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.